Recent Quotes (30 days)

You have no recent quotes
chg | %

Clinigen Group PLC  

(Public, LON:CLIN)   Watch this stock  
534.62
-13.38 (-2.44%)
Apr 21 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 531.50 - 548.50
52 week 354.92 - 577.80
Open 548.00
Vol / Avg. 86,283.00/116,325.00
Mkt cap 440.08M*
P/E 28.11
Div/yield 1.10/0.60*
EPS 0.19*
Shares 82.56M
Beta     -
Inst. own     -
*GBP

Key stats and ratios

Q2 (Jun '14) 2014
Net profit margin 13.91% 12.80%
Operating margin 18.24% 16.99%
EBITD margin - 21.18%
Return on average assets 18.65% 17.66%
Return on average equity 29.14% 27.65%
Employees 107 -
CDP Score - -

Address

Pitcairn House Crown Square, Centrum 100 BURTON ON TRENT
BURTON UPON TRENT, DE14 2WW
United Kingdom - Map
+44-1283-494340 (Phone)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Clinigen Group plc (Clinigen) is a United-kingdom specialty pharmaceuticals and services business company. It operates in three segments: Clinical Trial Supply, Specialty Pharmaceuticals and Global Access Programs. Clinical Trial Supply (Clinigen CTS) sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies. Specialty Pharmaceuticals (Clinigen SP) manufactures and distributes its own and in-licensed specialist, hospital-only medicines across the world. Global Access Programs (Clinigen GAP) specializes in the consultancy, development, management and implementation of global access programs for biotechnology and pharmaceutical companies. It has added two oncology support products with the acquisition of Savene and Ethyol, together with Cardioxane bringing this portfolio to three and with the two anti-infectives (Foscavir and Vibativ), the total portfolio to five.

Officers and directors

Peter Lutz George Chief Executive Officer, Director
Robin Andrew John Sibson Secretary, Non-Executive Director
Shaun Edward Chilton Chief Operating Officer, Director
Age: 45
Paul Thomas Chief Technical Officer
Peter Vance Allen Independent Non-Executive Chairman of the Board
Age: 57
John Hartup Independent Non-Executive Director
Ian J. Nicholson MBA Independent Non-Executive Director